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The optimal dose of vitamin D in growing girls
during academic years: a randomized trial
Mehrdad SHAKINBA, Samane TEFAGH, Zahra NAFEI

Aim: Prevalence of vitamin D deficiency is remarkable during childhood and adolescence throughout the world.
Sufficient intake of vitamin D contributes to a number of health outcomes. The aim of this study was to specify the
optimal dose of vitamin D in growing girls in a Muslim country during an academic year.
Materials and methods: This randomized clinical trial study was carried out in Yazd in the center of Iran in 2007;120
junior high school girls (aged 12-15 years) were randomly divided into 4 groups. Sixty students in groups I and II were
treated for vitamin D deficiency with 300,000 IU vitamin D3 and then randomly received 50,000 U/monthly or
100,000IU/3 months vitamin D3; 60 other students in groups III and IV received 50,000 IU/3 months and 100,000/3
months from the beginning of the academic year. Medication continued for the entire academic year; 1 month after the
last dose, serum 25(OH)D levels were measured.
Results: The mean level of 25 (OH) D was 29.7 ± 4.60 ng/mL in group I and 30 ± 5.61 ng/mL in group II. Mean serum
levels of 25 (OH) D were 15.2 ± 6 ng/mL and 23 ± 6.8 ng/mL for groups III and IV, respectively.
Conclusion: Neither doses of about 800 IU/day nor 1000 IU/day are sufficient to maintain 25(OH)D in optimal level (>
20 ng/mL) for all, but after the treatment of deficiency, intakes of about 1000 IU/day or 2000 IU/day of vitamin D
maintained optimal level in all of the students.
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Introduction
Vitamin D is an essential hormone for growth and development of bones in children and strong
skeletal structure in adults (1). In vitamin D deficiency, only 10%-15% of calcium of normal diet
is absorbed. This amount increases to 40% in the presence of adequate vitamin D (2,3). Moreover,
epidemiologic studies show vitamin D deficiency increases the risk of important diseases like
malignancy, cardiovascular disease, hypertension, stroke, diabetes, multiple sclerosis, rheumatoid
arthritis, and inflammatory bowel disease (4). Many studies in recent years have demonstrated that
vitamin D deficiency could exist in children and young adults without any obvious sign or
symptoms (5-12). Girls particularly are more prone to vitamin D deficiency because of their less
exposure to the sun and also their limited outdoor activities (5). Since about 35% of bone mass is
acquired during 4 years around puberty (13) it seems rational to pay special attention to this age
group. Diagnosis, treatment, and prevention of vitamin D deficiency in adolescents could, therefore,
be very important for their future health (14). In Iran, primary evaluation demonstrated a high
percentage of vitamin D deficiency in different age groups and in various locations especially in
winter (15-19).
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There are different ways to receive sufficient
vitamin D: either enough exposure to sunshine or
consumption of supplements separately or in
combination with fortified foods. Considering the
importance of puberty, in some countries (e.g. France
and Argentina) in which foods are not fortified,
vitamin D supplements are offered to the girls in bolus
doses every few months (18,20-22). Currently
recommended intakes of vitamin D are 200-400
IU/day for young adults. These recommendations are
not sufficient to reach the optimal 25(OH)D
concentration in most of the population. For the
majority of endpoints, an advantageous serum
concentration of 25(OH)D is 30 ng/mL (4). The
recommended dose of vitamin D for serum 25(OH)D
level of 30 ng/mL in 50% of subjects is 1000 IU/day
and for 88% of them is 4000 IU/day (23,24).
Results of several studies supported that intake of
vitamin D 4000-10000 IU/day for adults and 2000
IU/day for children over the age of 1 is safe and
sufficient (23,25).
Studies have investigated the required daily dose
of vitamin D for adults (26,27); however, further
studies are needed to evaluate the best dose of vitamin
D for optimal 25(OH)D concentrations in healthy
growing children and adolescents.
In view of the high prevalence of vitamin D
deficiency among girls in Yazd (28) this study was
designed to determine the adequate amount of
vitamin D to maintain a level more than 20 ng/mL
through academic years. Yazd is one the sunniest
provinces in the country and the Middle East, and,
therefore, this study could reveal the minimum
requirement of vitamin D in other areas with less
sunshine than our region.

bone, liver, kidney, gastrointestinal, and metabolic
diseases. None of the students had been consuming
any vitamin D supplements. Students were chosen
randomly and after an explanatory session to describe
the details of experiment to the parents and students,
their consents were taken. Students were then
arbitrarily divided into 4 groups: 60 in group I and II
who treated as vitamin D deficiency with 300,000
vitamin D3 and then randomly received 50,000 IU
each month (about 2000 IU/day) or 100,000 IU/3
months (about 1000 IU/day), 30 in group III received
50,000 IU/3 months (400 IU/day), and 30 in group IV
received 100,000 IU/3 months (about 1000/day). A
questionnaire was filled face to face for each student.
Height, weight, and the stage of their puberty (Tanner
stage) were then assessed. Vitamin D3 was given as a
pearl (50,000 units, Alhavi Company Iran) to groups.
The second and complementary doses (identical to
dose one) were given at the intervals up to the end of
the academic year. An information pack on side
effects of vitamin D along with a questionnaire was
provided for participants to fill if any of side effects
occurred within 2 weeks of taking doses. After 2
weeks all the questionnaires were collected. One
month after taking the final dose, a 3-5 mL blood
sample was taken and assessed for 25(OH)D. The
blood samples were transferred to the laboratory
where they were centrifuged and frozen at -20 °C.
Chemiluminescence immunoassay (DiaSorin,
LIAISON® 25 OH Vitamin D assay) was used to
measure 25(OH)D (as a main indicator of vitamin D).
SPSS was used to analyse the data where statistical
descriptive and analytic tests like mean (SD), t-test,
and Mann-Whitney were applied. P < 0.05 was
considered as the significant level of differences.
Results

Methods
This study was conducted as a randomised clinical
trial on the female students at junior high school
(aged 12-15 years) in Yazd during autumn and winter
2007. A total sample size of 120 subjects was
calculated based on a previous study (20), considering
CI = 95%, study power of 80%, SD1 = 4.4 ng/mL, SD2
= 4.6 ng/mL and minimal clinical differences (d = 3.3
ng/mL) with loss to follow up of 20%. The students
were all healthy without any history of endocrine,
34

One hundred and twenty students were enrolled
in this study. Two students in group I and 7 students
in group II were eliminated because of their changing
school or not using the right dose. In the 2 groups
who were treated first as deficient, the mean levels of
25(OH)D were 29.7 ± 4.60 ng/mL in the 50,000 IU
group and 30 ± 5.61 ng/mL in the 100,000 IU group.
There were no significant differences in serum level
means (P value = 0.75 t-test). The range of serum
25(OH)D level in the 1000 IU/day group was 20.34-
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36.23 ng/mL and while it was 20.43-47.88 in the 2000
IU/day group. All the students who received vitamin
D had serum level of > 20 ng/mL. Serum 25(OH)D
levels in 53.5% of 2000 IU/day group and 43.5% of
1000 IU/day group were > 30 ng/mL. The Table shows
the vitamin levels at the end of the academic year.
In the other 2 groups mean serum levels of
25(OH)D were 15.2 ± 6 ng/mL and 23 ± 6.8 ng/mL
for groups III and IV, respectively. Differences
between means in groups III and IV were significant
(PV = 0.0000). The range of serum 25(OH)D level in
group III was 7-27 ng/mL while it was 13.4-37.5 in
group IV. Neither dosage produced serum levels of
25(OH)D above 20 ng/mL in all cases, but in group
IV all had levels of 25(OH) more than 12 ng/mL and
55% more than 20 ng/mL. In group III only 13% had
levels of 25(OH) more than 20 ng/mL. All these doses
were safe for all of the students although some
complained about headaches and nausea for which
none of them needed any medical care.

Intake of vitamin D 1600 IU/day to maintain
serum 25(OH)D concentrations > 32 ng/mL in 97.5%
of the 20- to 40-year-old adults was suggested by
Cashman et al. (26), but Heaney et al. recommended
2
5000 IU/day for this purpose ( 5). Although the exact
optimal consumption dose of daily vitamin D is not
determined, 2000 units/day has been suggested to be
safe for adolescents (31). In a study carried out in
French adolescents aged 10-15 years, 100,000 units of
vitamin D every 3 months during winter were able to
raise their serum level of vitamin D above 20 ng/mL
with decreasing parathyroid hormone levels. This
study is similar to our study regarding the duration
and the age of participants (30). In our study, after 9
months, 36% of students who received vitamin D
2000 IU/day had serum 25(OH)D concentrations >
32 ng/mL. It seems that a greater requirement of
vitamin D in adolescent girls or severe initial
deficiencies in this region could be reasons for these
differences.
Conclusion

Discussion
In this study we evaluated the effect of 4 oral
vitamin D bolus doses on 25(OH)D level in junior
high school girls in Yazd (with its geographical
location of 30°N). The required serum 25(OH)D level
is the point which avoids serum parathyroid hormone
(PTH) elevation. Several studies estimated this point
to be between 8 and 35 ng/mL, but for most of the
population, 25(OH)D level of 20 ng/mL or even
higher is considered appropriate (29).

Results of this study show that in the area with
high prevalence of vitamin D deficiency (more than
50%), the recommended dose of neither 400 IU/day
nor 800 IU/day is sufficient to maintain optimal level
in all. However, after treatment of deficiency with
300,000 IU of vitamin D, both doses of 1000 or 2000
IU/day would maintain serum 25(OH)D
concentrations > 20 ng/mL in all of the samples
during academic years. If we consider level more than
30 ng/mL as the ideal level our study revealed higher
doses than what we use should be recommend.

Table. The distribution of 25 OH vitamin D among treated groups at the end of the academic year.
100,000 unit/
3 months Group
IV (n: 30)

50,000 unit/
3 months Group
III (n: 30)

300,000 IU + 100, 1000/
3 months Group
II (n: 23)

300,000 IU + 50,000/months
Group I (n: 28)

0%

13.5%

zero

zero

Severe deficiency (25(OH)D<10)

45%

%73

zero
–

zero

Deficiency 25(OH)D=10-20

35.5%

10.8%

57%
–

47%

Adequate 25(OH)D=20-30

19.5%

2.7%

43%
–

53%

Ideal 25(OH)D=30-100

Groups
Level 25OH-VITD

35

Optimal vitamin D dose in girls

Acknowledgment
The authors wish to thank the students and
parents who took part in this study. We also would
like to thank F. Shamsi for her contribution in the

statistics part of our manuscript. This article is based
on a research conducted by Dr S. Tefagh, as her
dissertation for medical degree, which was supervised
by Dr Shakiba.

References
1.

Holick MF. Vitamin D deficiency. N Engl J Med 2007; 357: 26681.

2.

3.

4.
5.

6.

15.

Holick MF. Vitamin D: The underappreciated D-lightful
hormone that is important for skeletal and cellular health. Curr
Opin Endocrinol Diabetes 2002; 9: 87-98.

Moussavi M, Heidarpour R, Aminorroaya A, Pournaghshband
Z, Amini M. Prevalence of vitamin D deficiency in Isfahani high
school students in 2004. Horm Res 2005; 64: 144-8.

16.

Heaney RP, Dowell MS, Hale CA, Bendich A. Calcium
absorption varies within the reference range for serum 25hydroxyvitamin D. J Am Coll Nutr 2003; 22: 142-6.

Hashemipour S, Larijani B, Adibi H, Javadi E, Sedaghat M,
Pajouhi M et al. Vitamin D deficiency and causative factors in
the population of Tehran. BMC Public Health 2004; 25; 4: 38

17.

Maghbooli Z, Hossein-Nezhad A, Shafaei AR, Karimi F, Madani
FS, Larijani B. Vitamin D status in mothers and their newborns
in Iran. BMC Pregnancy Childbirth 2007; 12; 7: 1.

18.

Dahifar H, Faraji A, Yassobi S, Ghorbani A. Asymptomatic
rickets in adolescent girls. Indian J Pediatr 2007; 74: 571-5.

19.

Rabbani A, Alavian SM, Motlagh ME, Ashtiani MT, Ardalan G,
Salavati A et al. Vitamin D Insufficiency among Children and
Adolescents Living in Tehran, Iran. J Trop Pediatr 2009; 55: 18991.

20.

Maalouf J, Nabulsi M, Vieth R, Kimball S, El-Rassi R, Mahfoud
Z et al. Short- and long-term safety of weekly high-dose vitamin
D3 supplementation in school children. J Clin Endocrinol
Metab 2008; 93: 2693-701.

21.

Tau C, Ciriani V, Scaiola E, Acuña M. Twice single doses of
100,000 IU of vitamin D in winter is adequate and safe for
prevention of vitamin D deficiency in healthy children from
Ushuaia, Tierra Del Fuego, Argentina. J Steroid Biochem Mol
Biol 2007; 103: 651-4.

22.

Duhamel JF, Zeghoud F, Sempé M, Boudailliez B, Odièvre M,
Laurans M et al. Prevention of vitamin D deficiency in
adolescents and pre-adolescents. An interventional multicenter
study on the biological effect of repeated doses of 100,000 IU of
vitamin D3. Arch Pediatr 2000; 7: 148-53.

Cannell JJ, Hollis BW. Use of vitamin D in clinical practice.
Altern Med Rev 2008; 13: 6-20.
El-Hajj Fuleihan G, Nabulsi M, Choucair M, Salamoun M, Hajj
Shahine C, Kizirian A et al. Hypovitaminosis D in healthy
schoolchildren. Pediatrics 2001; 107: E53.
Du X, Greenfield H, Fraser DR, Ge K, Trube A, Wang Y.
Vitamin D deficiency and associated factors in adolescent girls
in Beijing. Am J Clin Nutr 2001; 74: 494-500.

7.

Guillemant J, Taupin P, Le HT, Taright N, Allemandou A, Pérès
G et al. Vitamin D status during puberty in French healthy male
adolescents. Osteoporos Int 1999; 10: 222-5.

8.

Rovner AJ, O'Brien KO. Hypovitaminosis D among healthy
children in the United States: a review of the current evidence.
Arch Pediatr Adolesc Med 2008; 162: 513-9.

9.

Gordon CM, DePeter KC, Feldman HA, Grace E, Emans SJ.
Prevalence of vitamin D deficiency among healthy adolescents.
Arch Pediatr Adolesc Med 2004; 158: 531-7.

10.

Lehtonen-Veromaa MK, Möttönen TT, Nuotio IO, Irjala KM,
Leino AE, Viikari JS. Vitamin D and attainment of peak bone
mass among peripubertal Finnish girls: a 3-y prospective study.
Am J Clin Nutr 2002; 76: 1446-53.

11.

Outila TA, Kärkkäinen MU, Lamberg-Allardt CJ. Vitamin D
status affects serum parathyroid hormone concentrations
during winter in female adolescents: associations with forearm
bone mineral density. Am J Clin Nutr 2001; 74: 206-10.

23.

Bischoff-Ferrari HA, Giovannucci E, Willett WC, Dietrich T,
Dawson-Hughes B. Estimation of optimal serum concentrations
of 25-hydroxyvitamin D for multiple health outcomes. Am J
Clin Nutr 2006; 84: 18-28.

12.

Looker AC, Dawson-Hughes B, Calvo MS, Gunter EW, Sahyoun
NR. Serum 25-hydroxyvitamin D status of adolescents and
adults in two seasonal subpopulations from NHANES III . Bone
2002; 30: 771-7.

24.

Vieth R, Chan PC, MacFarlane GD. Efficacy and safety of
vitamin D3 intake exceeding the lowest observed adverse effect
level. Am J Clin Nutr 2001; 73: 288-94.

25.

13.

Das G, Crocombe S, McGrath M, Berry JL, Mughal MZ.
Hypovitaminosis D among healthy adolescent girls attending
an inner city school. Arch Dis Child 2006; 91: 569-72.

Heaney RP, Davies KM, Chen TC, Holick MF, Barger-Lux MJ.
Human serum 25-hydroxycholecalciferol response to extended
oral dosing with cholecalciferol. Am J Clin Nutr. 2003; 77: 20410.

14.

Huh SY, Gordon CM. Vitamin D deficiency in children and
adolescents: epidemiology, impact and treatment. Rev Endocr
Metab Disord 2008; 9: 161-70.

26.

Cashman KD, Hill TR, Lucey AJ, Taylor N, Seamans KM,
Muldowney S et al. Estimation of the dietary requirement for
vitamin D in healthy adults. Am J Clin Nutr 2008; 88: 1535-42.

36

M. SHAKINBA, S. TEFAGH, Z. NAFEI

27.

Cannell JJ, Hollis BW, Zasloff M, Heaney RP. Diagnosis and
treatment of vitamin D deficiency 2008; 9: 107-18.

28.

Shakiba M, Nafei Z, Lotfi MH, Shajari A. Prevalence of Vitamin
D Deficiency among Female Students in Secondary Guidance
School in Yazd City, Acta Medica Iranica 2009; 47: 209-14.

29.

Lips P. Which circulating level of 25-hydroxyvitamin D is
appropriate? J Steroid Biochem Mol Biol 2004; 89-90: 611-4.

30.

Duhamel JF, Zeghoud F, Sempé M, Boudailliez B, Odièvre M,
Laurans M et al. Prevention of vitamin D deficiency in
adolescents and pre-adolescents. An interventional multi center
study on the biological effect of repeated doses of 100,000 IU of
vitamin D3. Arch Pediatr 2000; 7: 148-53.

31.

Maalouf J, Nabulsi M, Vieth R, Kimball S, El-Rassi R, Mahfoud
Z et al. Short- and long-term safety of weekly high-dose vitamin
D3 supplementation in school children. J Clin Endocrinol
Metab 2008; 93: 2693-701.

37

